Pharmacological interventions in myopia management
- PMID: 31409953
- PMCID: PMC6688412
Pharmacological interventions in myopia management
Figures
References
-
- Chia A, Lu QS, Tan D. Five-year clinical trial on Atropine for the Treatment of Myopia 2: Myopia Control with atropine 0.01% eyedrops. Ophthalmol 2016; 123: 391–399. - PubMed
-
- Yam JC, Jiang Y, Tang SM, Law AKP, et al. Low-concentration Atropine for Myopia Progression (LAMP) study: a randomized, double-blinded, placebo-controlled trial of 0.05%, 0.025%, and 0.01% atropine eye drops in myopia control. Ophthalmol 2019; 126: 113–124. - PubMed
-
- Chia A, Chua W-H, Cheung Y-B, Wong W-L, et al. Atropine for the Treatment of Childhood Myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (ATOM2). Ophthalmol 2012; 119: 347–354. - PubMed
-
- Siatkowski RM, Cotter SA, Crockett RS, Miller JM, et al. Two-year multicenter, randomized, double-masked, placebo-controlled, parallel safety and efficacy study of 2% pirenzepine ophthalmic gel in children with myopia. J AAPOS 2008; 12: 332–339. - PubMed
LinkOut - more resources
Full Text Sources